TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06801145

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education Video
Description: 3 days before the surgery, patients were watched the training video.

Intervention type: OTHER
Group type: OTHER
Intervention: Training video will not be watched group
Description: No training was given about the intensive care process
Study: NCT06800105

Intervention type: OTHER
Intervention: High fat smoothie
Description: Participants will consume a standardized 490 kcal high-fat smoothie, consisting of 57% fat, 23% carbohydrate, and 20% protein.
Study: NCT06801197

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: MI-Coach: ED Mobile App
Description: The MI-Coach: ED mobile app is a self-guided intervention designed to enhance motivation and readiness for treatment in adults with eating disorders. The app includes seven sequential modules based on motivational interviewing (MI) principles, addressing ambivalence, self-acceptance, compassionate motivation, behavior change goals, sustain and change talk, commitment language, and relapse prevention. Each module incorporates interactive content, including educational videos, articles, and exercises, tailored to support motivation across a range of eating disorder diagnoses. The app is designed to be user-friendly and scalable, providing an accessible, cost-effective solution for individuals on waitlists for formal eating disorder treatment.

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: MI-Coach: ED Mobile App
Description: The MI-Coach: ED mobile app is a self-guided intervention designed to enhance motivation and readiness for treatment in adults with eating disorders. The app includes seven sequential modules based on motivational interviewing (MI) principles, addressing ambivalence, self-acceptance, compassionate motivation, behavior change goals, sustain and change talk, commitment language, and relapse prevention. Each module incorporates interactive content, including educational videos, articles, and exercises, tailored to support motivation across a range of eating disorder diagnoses. The app is designed to be user-friendly and scalable, providing an accessible, cost-effective solution for individuals on waitlists for formal eating disorder treatment.
Study: NCT06801353

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Stapokibart
Description: Stapokibart subcutaneously every two weeks

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mometasone Furoate Nasal Spray (MFNS)
Description: mometasone furoate nasal spray 200 μg once daily
Study: NCT06800651

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JMKX003142 will be administered orally
Description: JMKX003142 will be administered orally

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Plcacebo
Description: matched to JMKX003142
Study: NCT06801054

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tenecteplase (TNK) (0.25 mg/kg, to maximum of 25mg)
Description: All patients will receive a second dose of tenecteplase.
Study: NCT06800677

Intervention type: PROCEDURE
Intervention: Hysterectomy
Description: Elective hysterectomy

Intervention type: PROCEDURE
Intervention: Hysterectomy
Description: Elective hysterectomy
Study: NCT06800898

Intervention type: OTHER
Intervention: Blood samples and Questionnaires
Description: Blood samples for methylation of the promoter of the OX-A and OX-B genes and questionnaires:~Eating Disorder Examination Q Eating Disorder Inventory 3 Major Depression Inventory Symptom Checklist-revised ESS - Epworth Sleepiness Scale Pittsburgh Sleep Quality Index Horne \& Ostberg questionnaire

Intervention type: OTHER
Intervention: Blood samples and Questionnaires
Description: Blood samples for methylation of the promoter of the OX-A and OX-B genes and questionnaires:~Eating Disorder Examination Q Eating Disorder Inventory 3 Major Depression Inventory Symptom Checklist-revised ESS - Epworth Sleepiness Scale Pittsburgh Sleep Quality Index Horne \& Ostberg questionnaire
Study: NCT06798298

Intervention type: GENETIC
Intervention: Non-interventional
Description: No study drug administered. Long-term follow-up only.
Study: NCT05126277

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ianalumab s.c. q4w
Description: ianalumab s.c. q4w in addition to SoC

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ianalumab s.c. q12w
Description: ianalumab s.c. q12w in addition to SoC

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo s.c.
Description: placebo s.c. q4w in addition to SoC
Study: NCT06801847

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Socialization
Description: Socialization lasting from 30-60 minutes each session

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Socialization
Description: Socialization lasting from 30-60 minutes each session

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Socialization
Description: Socialization lasting from 30-60 minutes each session

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Walking
Description: Twice weekly walking (30 minutes)

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Moderate Exercise
Description: Twice weekly moderate exercise (30 minutes)
Study: NCT06801483

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Strengthening
Description: All subjects will recieve an ankle muscle strenghening training program twice a week for six weeks.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Strengthening
Description: All subjects will recieve an ankle muscle strenghening training program twice a week for six weeks.
Study: NCT04252547

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control
Description: The preprocedural measurements (weight, heart rate, and oxygen saturation) will be recorded before feeding when they are included in the study and then they will be breastfed by their mothers. The chronometer will be started at that moment he/she begins sucking and terminated when he/she stops. Also, the infant's heart rate and oxygen saturation will continue to be recorded during the breastfeeding process. When the breastfeeding process is over, the infant will be allowed to rest in his/her mother's arms for two minutes and his/her physiological parameters will be recorded. Following the breastfeeding process, the infant will be weighed without a diaper change and his/her weight will be recorded. When the care process is over, it will be taken back in the incubator to sleep.
Study: NCT06115135

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: All subjects in Dose Level 0 will receive 1) venetoclax, PO, at 400 mg every day (QD) on Days 1-28 of a 28-day cycle, 2) dexamethasone 40 mg IV, once weekly on Days 1, 8, 15, and 22 of a 28-day cycle; and 3) isatuximab 10mg/kg, IV, on Days 1, 8, 15, and 22 of the first 28-day cycle, and then Days 1 and 15 during subsequent 28-day cycles.
Study: NCT04610372

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Hypofractionated external beam radiotherapy
Description: 5500 cGy/20 fractions delivered 5 days per week over 4 weeks

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: High dose rate brachytherapy
Description: A single fraction of 19 Gy is delivered from an automated afterloading Iridium-192 source via interstitial catheters placed under ultrasound guidance

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Permanent seed implant
Description: Iodine-125 radioactive seeds are implanted permanently in the prostate in a single procedure under transrectal ultrasound guidance
Study: NCT06698640

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Automated SMS
Description: Participants will receive automated SMS messages reminding them of their Well-Child Visits. These messages will be standardized and sent at intervals designed to prompt appointment attendance.
Study: NCT04610372

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy
Description: External radiation using SABR technology delivers 36.25 Gy to the prostate in 5 fractions given either once weekly for 5 weeks or every second day over 2 weeks.
Study: NCT05337371

Intervention type: DEVICE
Intervention: ECG patch (Philips ePatch® 2.0)
Description: The ECG patch will be put on the patients chest to monitor cardiac activity for a total time period of 14 days after cardiac arrest.
Study: NCT05551663

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Isometric exercise training
Description: Participants randomised to the intervention will perform a 4-week programme of isometric exercise training.
Study: NCT04655430

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 3-second SDF application
Description: Dosage: 3-second 38% SDF solution application

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 5-second SDF application
Description: Dosage: 5-second 38% SDF solution application

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 10-second SDF application
Description: Dosage: 10-second 38% SDF solution application
Study: NCT06698640

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Automated SMS + Scheduling Assistance
Description: Participants will receive the same automated SMS messages as in Arm 2, but with the added component of proactive appointment scheduling assistance. This may include options for scheduling directly through the SMS platform or follow-up messages encouraging appointment setting.
Study: NCT06699108

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VGR-R01
Description: Subretinal injection of VGR-R01 (0.1 mL)
Study: NCT06698809

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active tPBM
Description: tPBM is a neuromodulatory treatment that uses red and/or near infrared light to penetrate the cortex and can alter both cerebral metabolism and blood flow. Subjects will receive treatment for approximately 12 minutes per treatment.
Study: NCT06699381

Intervention type: DEVICE
Intervention: use of spinal mouse
Description: Spinal Mouse (SM) is an external non-invasive measurement device that evaluates the spinal angle and shape in the frontal and sagittal planes

Intervention type: DIAGNOSTIC_TEST
Intervention: Brunnstrom's Hemiplegia Recovery Staging
Description: According to Brunnstrom's stages of recovery, the individual will be identified at which stage

Intervention type: DIAGNOSTIC_TEST
Intervention: The six minute walking test (6MWT)
Description: It evaluates the functional capacity of the individual and it provides valuable information regarding all the systems during physical activity, including pulmonary and cardiovascular systems, blood circulation, neuromuscular units, body metabolism, and peripheral circulation
Study: NCT04655430

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 15-second SDF application
Description: Dosage: 15-second 38% SDF solution application
Study: NCT06030466

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: With virtual standardized patients
Description: The virtual standardized patient is a software system that presents on a computer screen like a video conference, allowing medical students to interact with it for medical consultation. The virtual character modeling adopts 3D model, the expression of the character is delicate, and the voice feedback is clear. After the students' questions are asked by voice recognition and key words are extracted, appropriate responses are given.

Intervention type: OTHER
Group type: OTHER
Intervention: With physical standardized patients
Description: The physical standardized patient is a real person who has received professional training courses in the department of medical education of National Taiwan University Hospital, and can help medical students practice consultations.
Study: NCT06132477

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: GLP-1 receptor agonist
Description: Randomized to continue or discontinue GLP-1 receptor agonists after bariatric surgery
Study: NCT05892770

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zinc gluconate supplement
Description: Subjects will take a 50 mg zinc gluconate supplement at breakfast for the five days leading up to their next injection appointment. They will also answer questionnaires and provide audio recordings at various time points of the two injection cycles, which is roughly six months.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Botulinum toxin type A
Description: This is the current standard of care for treatment of spasmodic dysphonia. Botox injection goes into the vocal cord muscle, and will be occur in both the control and experimental arms of the study.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A
Description: This is the current standard of care for treatment of spasmodic dysphonia. Botox injection goes into the vocal cord muscle, and will be occur in both the control and experimental arms of the study.
Study: NCT05799521

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Optate
Description: Alkaline Buffer

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Normal Saline
Study: NCT05699551

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise regimen
Description: Exercise will take place Monday, Wednesday, and Friday from 12:00-1:00 pm for 6 weeks. Aerobic exercise will consist of walking, beginning with a 10-minute duration, with gradual progression to 20 minutes. Muscle strength, endurance and range-of-motion exercise will then be performed. Muscle strength and endurance training will begin using no weight and performing one set of 6 repetitions. Progression using added resistance in the form of dumbbell weights (1-6 lbs.) and increased sets and repetitions will be applied as Subjects become increasingly fit. For static range of motion exercise, positions will be held for 10-15 seconds in the beginning and increased over time. Exercise will be kept at a moderate level of intensity. Each session will then end with relaxation training.
Study: NCT05623475

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: OSCEs
Description: Scenario-based education intervention, including objective structured clinical examinations (OSCEs)

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Lecture
Description: Face-to-face Education using Delirium Care Flip Chart

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lecture
Description: Face-to-face Education using Delirium Care Flip Chart

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: E-learning
Description: Delirium care video

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: E-learning
Description: Delirium care video
Study: NCT05709561

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Acupresur
Description: acupressure application was applied 2 times a week for a total of 12 weeks and 24 times.
Study: NCT06699381

Intervention type: DIAGNOSTIC_TEST
Intervention: Functional Reach Test (FRT)
Description: Functional Reach Test (FRT) is a clinical outcome measure and assessment tool for ascertaining dynamic balance in in simple task.~In standing, measures the distance between the length of an outstretched arm in a maximal forward reach, while maintaining a fixed base of support.~This information is correlated with risk of falling A number of factors exert a major influence on this evaluation: Research revealed that movement strategy and reduced spinal flexibility both affect reach distance.

Intervention type: DIAGNOSTIC_TEST
Intervention: Mini Balance Evaluation Systems Test (Mini-BESTest)
Description: This test measures dynamic balance, functional mobility, and gait. It is commonly used in populations who have or have had multiple sclerosis (MS), Parkinson disease (PD), strokes, spinal cord injury (SCI), or cancer.~The Mini-BESTest was developed in 2010 from the Balance Evaluation Systems Test (BESTest), then revised in 2013 to clarify inconsistencies in scoring. The scoring instructions were different in the published and online versions. The revision clarified that the Mini-BESTest should be scored out of 28 points. Explanations for how to score items 3, 6, and 14 were also given.~The Mini-BESTest consists of 14 items, including 4 of the 6 sections (anticipatory postural adjustments, reactive postural control, sensory orientation, and dynamic gait) from the BESTest.
Study: NCT05709561

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Mindfulness
Description: Mindfulness practice was applied with the students once a week for 8 weeks, accompanied by a researcher. Then, students were asked to apply for 3 cycles.

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Plasebo
Description: No intervention was applied to the control group.
Study: NCT05837611

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Deposit Contract
Description: A deposit contract requires individuals to put down money that is earned back contingently upon meeting their goals.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transdermal Alcohol Monitoring
Description: Using a SCRAM-Cam device participants will be monitored for their alcohol use.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Transdermal Alcohol Monitoring
Description: Using a SCRAM-Cam device participants will be monitored for their alcohol use.
Study: NCT06088394

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: Participants will be asked to assume supine lying position on the plinth and the following points will be located then needles will be inserted:~* CV3,4 \&5-40 mm needles at a depth of 1 cun perpendicular insertion.~* ST 25 bilaterally-40 mm needles at a depth of 1 cun oblique insertion.~* SP6 \& 9, K13\&7 bilaterally-25 mm needles at a depth of 0.5 cun perpendicular insertion. A total of 13 needles will be inserted at each session.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pelvic floor exercises
Description: pelvic floor muscle exercises can help strengthen pelvic floor muscle, which provides better control of urinary urgency by interfering with urethral-detrusor reflexes and inhibiting detrusor contractions

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pelvic floor exercises
Description: pelvic floor muscle exercises can help strengthen pelvic floor muscle, which provides better control of urinary urgency by interfering with urethral-detrusor reflexes and inhibiting detrusor contractions
Study: NCT06699381

Intervention type: DIAGNOSTIC_TEST
Intervention: The five Times Sit to Stand Test (5x Sit-To-Stand Test)
Description: It's used to asses functional lower limbs strength, transitional movements, balance, and fall risk in older adults.

Intervention type: DIAGNOSTIC_TEST
Intervention: The Postural Assessment Scale for Stroke (PASS)
Description: The Postural Assessment Scale for Stroke (PASS) is an outcome measure specifically designed to assess and monitor postural control after stroke. It was developed in 1999 as an adaptation of the Fugl-Meyer Assessment balance subscale\[1\]. It contains 12 four-level items of varying difficulty for assessing ability to maintain or change a given lying, sitting or standing posture

Intervention type: DIAGNOSTIC_TEST
Intervention: Postural Symmetry Index and Weight Transfer Symmetry
Description: It is a form of measurement in which two scales are used to calculate the weight transferred to the intact and stroke limb. The values obtained as a result of the test are calculated with formulas.

Intervention type: DIAGNOSTIC_TEST
Intervention: Measurement of the craniovertebral angle
Description: Measurement of the craniovertebral angle; the patient is asked to find the most natural position by flexion and extension of the head in the standing position and a photograph is taken with a digital camera from a distance of 1.5 m to the shoulder level of the patient and this process is repeated 3 times. The images obtained are then digitally calculated with the help of an appropriate program.
Study: NCT04655430

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 30-second SDF application
Description: Dosage: 30-second 38% SDF solution application

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 45-second SDF application
Description: Dosage: 45-second 38% SDF solution application

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 60-second SDF application
Description: Dosage: 60-second 38% SDF solution application

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 120-second SDF application
Description: Dosage: 120-second 38% SDF solution application

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 180-second SDF application
Description: Dosage: 180-second 38% SDF solution application
Study: NCT06226012

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: pulsed magnetic field
Description: Children in this group received pulsed magnetic therapy in addition to traditional exercise program

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low level laser
Description: Children in this group received low level laser therapy in addition to traditional exercise program